Low-dose IV Iron Sucrose for Treatment of Anemia in PD

A small study (n=18) of IV iron sucrose (200mg loading dose followed by 100mg monthly for 5 consecutive months) found reductions in ESA dosing for 5 patients and discontinuation in one, with no reported side effects.

Read the abstract » | (added 2020-01-09)

Tags: IV Iron Sucrose, Anemia, ESA Dosing